Company

Alloy Therapeutics

Biotech infrastructure company providing drug discovery and development services and technology to pharma and biotech companies worldwide, bridging wet lab capabilities with AI and machine learning

AIHealthcare & Biotech

People

Errik Andersonfounder

Funding History

Apr 20, 2026Series E

Alloy Therapeutics raised a $40M Series E to expand its full-stack AI biotech infrastructure platform, which helps pharma and biotech companies discover and develop drugs. The company had not raised since 2022.

40M

News

Interviews (1)

Alloy Therapeutics raises $40M Series E to build full-stack AI biotech infrastructure across 17 time zones

20 Apr 2026